RAPS is closely monitoring developments in the Coronavirus (COVID-19) outbreak. See our public safety page for the latest updates.

Regulatory Focus™ > News Articles > Regulatory Policies Germane to FTC Oversight of Healthcare Product Advertising and Promotion

Regulatory Policies Germane to FTC Oversight of Healthcare Product Advertising and Promotion

Posted 01 May 2008 | By

The Food and Drug Administration (FDA) and Federal Trade Commission (FTC) have a symbiotic relationship in overseeing US healthcare product advertising and promotion. As a general rule, FTC regulates advertising for foods, over-the-counter drugs, dietary supplements, medical devices and cosmetics. FDA regulates the labeling for these products, as well as advertising and labeling for prescription drugs and restricted devices. This article focuses on advertising and promotional issues that are within FTC's jurisdiction.

Regulatory Focus newsletters

All the biggest regulatory news and happenings.

Subscribe

Regulatory Focus™ is doing essential, non-biased journalism during this unprecedented time. We appreciate your support as we bring you the news and intelligence you need to make an impact on global healthcare.

Regulatory Focus™ provides the intelligence you need to impact global healthcare during this crisis. Thank you for your support.